Virtu KCG Holdings’s Core Laboratories CLB Stock Holding History

Virtu KCG Holdings’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-4,890	Closed	-$587K	–	3186
2016 Q4	$587K	Buy	+4,890	New	+$541K	0.01%	1334
2016 Q2	–	Sell	-4,241	Closed	-$477K	–	2983
2016 Q1	$477K	Buy	4,241 +323	+8%	+$33.6K	0.01%	1236
2015 Q4	$426K	Buy	+3,918	New	+$448K	0.01%	1732
2015 Q3	–	Sell	-8,888	Closed	-$1.01M	–	3381
2015 Q2	$1.01M	Buy	8,888 +3,216	+57%	+$390K	0.02%	828
2015 Q1	$593K	Buy	5,672 +1,176	+26%	+$125K	0.01%	1205
2014 Q4	$541K	Buy	+4,496	New	+$591K	0.01%	1590
2014 Q2	–	Sell	-2,164	Closed	-$429K	–	3680
2014 Q1	$429K	Sell	2,164 -727	-25%	-$137K	0.01%	2129
2013 Q4	$552K	Buy	2,891 +297	+11%	+$55.3K	0.01%	1845
2013 Q3	$439K	Buy	+2,594	New	+$403K	0.01%	2160

Other funds holding CLB

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wedgewood Partners St Louis, Missouri $484M AUM 16.04% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Virtu KCG Holdings's CLB Position: Q1 2017 in Review

Virtu KCG Holdings sold out of Core Laboratories (CLB) in Q1 2017, closing a stake of 4,890 shares — an estimated $587K sold.

Virtu KCG Holdings first reported a position in CLB in Q3 2013 and held it in 9 quarters. The position peaked at $1.01M in Q2 2015. 360 funds tracked by Wall St. Rank hold CLB as of Q1 2017.

Virtu KCG Holdings reported no remaining Core Laboratories position as of Q1 2017 after selling out during the quarter.
Virtu KCG Holdings sold 4,890 Core Laboratories shares in Q1 2017, an estimated $587K.
Virtu KCG Holdings first reported a position in Core Laboratories in Q3 2013 and held it in 9 quarters.
Virtu KCG Holdings's Core Laboratories position peaked at $1.01M in Q2 2015.
360 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2017.

Based on Virtu KCG Holdings's 13F filing for Q1 2017, filed 12 May 2017.